108 related articles for article (PubMed ID: 38749017)
1. Comparison of the pregnancy outcomes of progestin-primed vs. antagonist ovarian stimulation in patients with poor ovarian response: a retrospective study.
Shi Z; Zhao W; Wu X; Bi X
Gynecol Endocrinol; 2024 May; 40(1):2352133. PubMed ID: 38749017
[TBL] [Abstract][Full Text] [Related]
2. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
Xiao ZN; Peng JL; Yang J; Xu WM
Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
[TBL] [Abstract][Full Text] [Related]
3. Progestin-primed ovarian stimulation is a feasible method for poor ovarian responders undergoing in IVF/ICSI compared to a GnRH antagonist protocol: A retrospective study.
Huang P; Tang M; Qin A
J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):99-102. PubMed ID: 30321608
[TBL] [Abstract][Full Text] [Related]
4. Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles.
Vidal MDM; Martínez F; Rodríguez I; Polyzos NP
Hum Reprod; 2024 May; 39(5):1098-1104. PubMed ID: 38498835
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis.
Du M; Zhang J; Li Z; Liu X; Li J; Liu W; Guan Y
Front Endocrinol (Lausanne); 2021; 12():705264. PubMed ID: 34589055
[TBL] [Abstract][Full Text] [Related]
6. Ovulation induction with high progesterone levels may be more suitable for elderly patients with low ovarian response.
Mu Z; Sa Y; Sun Z; Yi Y
J Gynecol Obstet Hum Reprod; 2021 Feb; 50(2):101661. PubMed ID: 31809957
[TBL] [Abstract][Full Text] [Related]
7. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations.
Zhou R; Dong M; Huang L; Wang S; Fan L; Liang X; Zhang X; Liu F
Front Endocrinol (Lausanne); 2023; 14():1117513. PubMed ID: 37143731
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial to compare the live birth rate of the first frozen embryo transfer following the progestin-primed ovarian stimulation protocol vs. the antagonist protocol in women with an anticipated high ovarian response.
Chen ZQ; Ai A; Zhang Y; Li H; Wang JY; Wang L; Ng EHY
Fertil Steril; 2024 Jun; 121(6):937-945. PubMed ID: 38272383
[TBL] [Abstract][Full Text] [Related]
10. Cumulative live birth rate of in vitro fertilization cycle via progestin-primed ovarian stimulation versus gonadotropin-releasing hormone antagonist protocol in infertile women with normal ovarian reserve: an open-label, randomized controlled trial.
Ye H; Shi L; Quan X; Hou M; Ma H; Xue S; Yu Z; Chen Q; Sun L
Hum Fertil (Camb); 2024 Dec; 27(1):2316005. PubMed ID: 38357937
[TBL] [Abstract][Full Text] [Related]
11. Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF.
Pai AH; Sung YJ; Li CJ; Lin CY; Chang CL
Reprod Biol Endocrinol; 2023 Aug; 21(1):72. PubMed ID: 37550681
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the cumulative live birth rates after 1 in vitro fertilization cycle in women using gonadotropin-releasing hormone antagonist protocol vs. progestin-primed ovarian stimulation: a propensity score-matched study.
Chen H; Teng XM; Sun ZL; Yao D; Wang Z; Chen ZQ
Fertil Steril; 2022 Oct; 118(4):701-712. PubMed ID: 35940929
[TBL] [Abstract][Full Text] [Related]
13. Comparison the effects of progestin-primed ovarian stimulation (PPOS) protocol and GnRH-a long protocol in patients with normal ovarian reserve function.
Xu S; Wang X; Zhang Y; Han Y; Zhang C
Gynecol Endocrinol; 2023 Dec; 39(1):2217263. PubMed ID: 37236243
[TBL] [Abstract][Full Text] [Related]
14. Non-inferiority of progestin-primed ovarian stimulation versus GnRH antagonist protocol: A propensity score-weighted analysis.
Duc Thang L; Bao Long H; Thi Thu Trang D; Ngoc Quy P; Thi Mai Phuong G; Thi Hanh B; Trong Thach T; Thi Lien Huong N; Hoang L; Hugues JN
J Formos Med Assoc; 2024 Apr; 123(4):523-529. PubMed ID: 38092654
[TBL] [Abstract][Full Text] [Related]
15. Effect of Progestin-primed Ovarian Stimulation Protocol on Outcomes of Aged Infertile Women Who Failed to Get Pregnant in the First IVF/ ICSI Cycle: A Self-controlled Study.
Chen YM; Qi QR; Xie QZ; Yang YF; Xia Y; Zhou XD
Curr Med Sci; 2018 Jun; 38(3):513-518. PubMed ID: 30074220
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
[TBL] [Abstract][Full Text] [Related]
17. Analysis of cumulative live birth rate and perinatal outcomes in young patients with low anti-müllerian hormone levels using two ovulation promotion protocols: A cohort study.
Li Z; Jia R; Wang K; Zhang J; Ren B; Guan Y
Front Endocrinol (Lausanne); 2022; 13():938500. PubMed ID: 35992097
[TBL] [Abstract][Full Text] [Related]
18. Fixed Gonadotropin-Releasing Hormone Antagonist Protocol
Dong M; Sun L; Huang L; Wang F; Zhang X; Liu F
Front Endocrinol (Lausanne); 2021; 12():690575. PubMed ID: 34867773
[TBL] [Abstract][Full Text] [Related]
19. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders.
Xia M; Zheng J
BMC Pregnancy Childbirth; 2021 May; 21(1):372. PubMed ID: 33975553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
